Curvebeam AI Ltd
ASX:CVB
Curvebeam AI Ltd
Curvebeam AI Ltd is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Hatfield, Pennsylvania. The company went IPO on 2023-08-23. Curvebeam AI Ltd is engaged in the research, design, and manufacturing of cone beam computed tomography (CT) imaging systems for the orthopedic specialties. The firm is engaged in providing point-of-care diagnostic cone beam CT imaging solutions with artificial intelligence (AI) and deep learning AI (DLAI). Its product categories include orthopedics and bone health. Its orthopedics products include HiRise, LineUP, pedCAT Premium, pedCAT, InReach, and CubeVue Software. Its bone health products include InReach HR-pQCT, and OSSView. HiRise is a bilateral, weight bearing CT imaging of the entire lower extremities including hips/pelvis, distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach HR-pQCT is a high resolution peripheral quantitative CT (HR-pQCT) imaging system designed for the point-of-care. OssView Bone Fragility software analyzes HR-pQCT images to measure the bone microarchitecture.
Curvebeam AI Ltd is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Hatfield, Pennsylvania. The company went IPO on 2023-08-23. Curvebeam AI Ltd is engaged in the research, design, and manufacturing of cone beam computed tomography (CT) imaging systems for the orthopedic specialties. The firm is engaged in providing point-of-care diagnostic cone beam CT imaging solutions with artificial intelligence (AI) and deep learning AI (DLAI). Its product categories include orthopedics and bone health. Its orthopedics products include HiRise, LineUP, pedCAT Premium, pedCAT, InReach, and CubeVue Software. Its bone health products include InReach HR-pQCT, and OSSView. HiRise is a bilateral, weight bearing CT imaging of the entire lower extremities including hips/pelvis, distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach HR-pQCT is a high resolution peripheral quantitative CT (HR-pQCT) imaging system designed for the point-of-care. OssView Bone Fragility software analyzes HR-pQCT images to measure the bone microarchitecture.
Order Intake: CurveBeam AI received 5 device orders in Q2 FY26, all from the U.S. market (4 HiRise, 1 LineUp).
China Investment Progress: The first $4 million milestone payment from WEGO Orthopaedics has transferred to an intermediary bank in Australia and is expected to clear to CurveBeam AI's account within 7 days.
Regulatory Milestones: The Chinese ODI approval for the full $10 million investment is secured; Chinese FDA (CFDA) clearance is targeted for calendar year 2026.
Stryker Partnership: Validation for Stryker MAKO integration is now an active project, with senior-level engagement and resource support from CurveBeam AI to expedite progress.
BMD Regulatory Progress: U.S. FDA clearance for the bone mineral density module (MDCT) is on track for midyear, with 400 patient data points submitted.
Europe Sales Timing: European sales remain slow due to pending decisions on German DVT payment levels, but management expects activity to pick up once resolved.
Cash Position: Pro-forma cash stands at just over $8 million, including the incoming WEGO milestone payment.
